VISKEN Side Effects

6789813-9 | Blood Pressure Increased, Malaise, Suffocation Feeling, Tachycardia, Tremor
on Jun 10, 2010 Female patient from BRAZIL , weighting 229.3 lb, was diagnosed with hypertension and was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, malaise, suffocation feeling, tachycardia, tremor. Visken dosage: 10 Mg, Once/single. During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ).

6789812-7 | Eclampsia, Feeling Cold, Hypertension
Patient was taking Visken (View Usage). Patient had the following side effects: eclampsia, feeling cold, hypertension on Jun 09, 2010 from BRAZIL Additional patient health information: Female patient , 42 years of age, weighting 280.0 lb, was diagnosed with hypertension, hyperthyroidism and. Visken dosage: 10 Mg, Q12h. During the same period patient was treated with PURAN T4 (75 Mg, Qd) (View Puran T4 Review and Puran T4 Label ). Patient was hospitalized.

6532759-1 | Blood Pressure Increased, Depression, Eclampsia, Headache, Incorrect Dose Administered
Adverse event was reported on Jan 05, 2010 by a Female patient taking Visken (View Usage) (Dosage: 5 Mg, Q6h) was diagnosed with hypertension and. Location: BRAZIL , 34 years of age, weighting 229.3 lb, After Visken was administered, patient had the following side effects: blood pressure increased, depression (What is depression?), eclampsia, headache (What is headache?), incorrect dose administered. Patient was hospitalized.

6337516-7 | Blood Pressure Decreased, Chest Pain, Dry Mouth, Feeling Abnormal, Fluid Retention, Hypertension, Palpitations, Ph Urine Decreased
on Aug 25, 2009 Female patient from BRAZIL , 27 years of age, weighting 310.9 lb, was diagnosed with hypertension and was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chest pain (What is chest pain?), dry mouth, feeling abnormal, fluid retention, hypertension, palpitations, ph urine decreased. Visken dosage: 10 Mg, Bid. During the same period patient was treated with FOLIC ACID (5 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), FERROUS SULFATE TAB (1 Tablet (300 Mg), Qd) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), METHYLDOPA (1 Tablet (500 Mg) Every 6 Hours) (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.


5949403-4 | Arthropathy, Mental Disorder, Musculoskeletal Pain
on Oct 30, 2008 Male patient from GERMANY , 64 years of age, was diagnosed with supraventricular extrasystoles, sinus tachycardia and was treated with Visken (View Usage). Patient had the following side effects: arthropathy, mental disorder, musculoskeletal pain. Visken dosage: 2.5 Mg, Tid.

5908790-3 | Caesarean Section
Patient was taking Visken (View Usage). After Visken was administered, patient had the following side effects: caesarean section on Sep 25, 2008 from Additional patient health information: Female patient , 38 years of age, was diagnosed with hypertension and. Visken dosage: 10 Mg. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METHYLDOPA (250 Mg, Bid) (View Methyldopa Review and Methyldopa Label ).

5908788-5 | Premature Baby, Respiratory Disorder Neonatal
Adverse event was reported on Sep 25, 2008 by a Male patient taking Visken (View Usage) (Dosage: 2 Df, Q8h) was diagnosed with hypertension and. Location: BRAZIL , weighting 4.68 lb, Patient experienced the following unwanted or unexpected effects: premature baby, respiratory disorder neonatal. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Daily) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METHYLDOPA (250 Mg Twice Daily With An Interval Of 6 Hours) (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.

5908779-4 | Abortion Spontaneous
on Sep 25, 2008 Female patient from BRAZIL , 38 years of age, was diagnosed with hypertension and was treated with Visken (View Usage). Patient had the following side effects: abortion spontaneous. Visken dosage: .

5865779-0 | Bronchiectasis, Interstitial Lung Disease, Lymphadenopathy, Pseudolymphoma, Skin Lesion
on Aug 22, 2008 Male patient from FRANCE , 74 years of age, was diagnosed with blood uric acid increased and was treated with Visken (View Usage). After Visken was administered, patient had the following side effects: bronchiectasis, interstitial lung disease, lymphadenopathy, pseudolymphoma, skin lesion. Visken dosage: Unk, Unk. During the same period patient was treated with ZYLORIC (1 Df, Qd) (View Zyloric Review and Zyloric Label ), ZANIDIP (Unk, Unk) (View Zanidip Review and Zanidip Label ). Patient was hospitalized.

5820180-0 | Arthropathy, Musculoskeletal Pain
Patient was taking Visken (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, musculoskeletal pain on Jul 16, 2008 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with supraventricular extrasystoles, sinus tachycardia and. Visken dosage: 2.5 Mg, Tid.

5809354-2 | Caesarean Section, Hypertension, Tremor
Adverse event was reported on Jul 03, 2008 by a Female patient taking Visken (View Usage) (Dosage: 1 Df, Bid) was diagnosed with pregnancy induced hypertension, anaemia and. Location: , 29 years of age, weighting 119.0 lb, Patient had the following side effects: caesarean section, hypertension, tremor. During the same period patient was treated with METHYLDOPA (500 Mg, Q8h) (View Methyldopa Review and Methyldopa Label ), NATALCARE (1 Df, Qd) (View Natalcare Review and Natalcare Label ), FERROUS SULFATE TAB (40 Mg, Qd) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5699981-8 | Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myalgia, Pain In Extremity
on Apr 01, 2008 Female patient from FRANCE , 83 years of age, weighting 127.9 lb, was diagnosed with essential hypertension and was treated with Visken (View Usage). After Visken was administered, patient had the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myalgia, pain in extremity. Visken dosage: 5 Mg, Bid. During the same period patient was treated with EXFORGE (View Exforge Review and Exforge Label ).

5524450-5 | Caesarean Section, Feeling Abnormal, Hypertension, Tachycardia, Tremor, Vomiting
on Nov 14, 2007 Female patient from BRAZIL , 21 years of age, weighting 220.5 lb, was diagnosed with hypertension and was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, feeling abnormal, hypertension, tachycardia, tremor, vomiting. Visken dosage: 5 Mg, Q12h.

5486317-0 | Abortion Spontaneous, Benign Hydatidiform Mole, Systemic Lupus Erythematosus
Patient was taking Visken (View Usage). Patient had the following side effects: abortion spontaneous, benign hydatidiform mole, systemic lupus erythematosus on Oct 08, 2007 from FRANCE Additional patient health information: Female patient , 26 years of age, was diagnosed with arrhythmia supraventricular and. Visken dosage: 1 Df, Qd. Patient was hospitalized.

5450866-1 | Eclampsia, Feeling Cold, Hypertension
Adverse event was reported on Sep 05, 2007 by a Female patient taking Visken (View Usage) (Dosage: 10 Mg, Q12h) was diagnosed with hypertension, hyperthyroidism and. Location: BRAZIL , 42 years of age, weighting 280.0 lb, After Visken was administered, patient had the following side effects: eclampsia, feeling cold, hypertension. During the same period patient was treated with PURAN T4 (75 Mg, Qd) (View Puran T4 Review and Puran T4 Label ). Patient was hospitalized.

5447174-1 | Anaphylactic Shock, Dysphonia, Dyspnoea, Electrocardiogram Qt Prolonged, Erythema, Eyelid Oedema, Heart Rate Increased, Hypertension, Lacrimation Increased
on Sep 05, 2007 Male patient from FRANCE , 76 years of age, was diagnosed with hypertension, sinusitis (What is sinusitis?) and was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, dysphonia, dyspnoea, electrocardiogram qt prolonged, erythema, eyelid oedema, heart rate increased, hypertension, lacrimation increased. Visken dosage: . During the same period patient was treated with TAVANIC (500 Mg, Once/single) (View Tavanic Review and Tavanic Label ), SOLU MEDROL (20 Mg, Once/single) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5401181-3 | Anaphylactic Shock, Dysphonia, Dyspnoea, Electrocardiogram Qt Prolonged, Erythema, Eyelid Oedema, Heart Rate Increased, Hypertension, Lacrimation Increased
on Jul 24, 2007 Male patient from FRANCE , 76 years of age, was diagnosed with hypertension, sinusitis (What is sinusitis?) and was treated with Visken (View Usage). Patient had the following side effects: anaphylactic shock, dysphonia, dyspnoea, electrocardiogram qt prolonged, erythema, eyelid oedema, heart rate increased, hypertension, lacrimation increased. Visken dosage: . During the same period patient was treated with TAVANIC (500 Mg, Once/single) (View Tavanic Review and Tavanic Label ), SOLU MEDROL (20 Mg, Once/single) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5373247-8 | Blood Pressure Increased, Insomnia, Malaise, Suffocation Feeling, Tachycardia, Throat Tightness, Tremor
Patient was taking Visken (View Usage). After Visken was administered, patient had the following side effects: blood pressure increased, insomnia, malaise, suffocation feeling, tachycardia, throat tightness, tremor on Jun 15, 2007 from BRAZIL Additional patient health information: Female patient , 27 years of age, weighting 229.3 lb, was diagnosed with hypertension and. Visken dosage: 10 Mg, Once/single. During the same period patient was treated with MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ).

5312710-2 | Abortion Spontaneous, Benign Hydatidiform Mole, Systemic Lupus Erythematosus
Adverse event was reported on Apr 18, 2007 by a Female patient taking Visken (View Usage) (Dosage: 1 Df, Qd) was diagnosed with arrhythmia supraventricular and. Location: FRANCE , 26 years of age, Patient experienced the following unwanted or unexpected effects: abortion spontaneous, benign hydatidiform mole, systemic lupus erythematosus. Patient was hospitalized.

5312140-3 | Abortion Spontaneous, Benign Hydatidiform Mole, Systemic Lupus Erythematosus
on Apr 18, 2007 Female patient from FRANCE , 26 years of age, was diagnosed with arrhythmia supraventricular and was treated with Visken (View Usage). Patient had the following side effects: abortion spontaneous, benign hydatidiform mole, systemic lupus erythematosus. Visken dosage: 1 Df, Qd. Patient was hospitalized.

5226961-9 | Abortion Spontaneous, Benign Hydatidiform Mole, Systemic Lupus Erythematosus
on Jan 22, 2007 Female patient from FRANCE , 26 years of age, was diagnosed with arrhythmia supraventricular and was treated with Visken (View Usage). After Visken was administered, patient had the following side effects: abortion spontaneous, benign hydatidiform mole, systemic lupus erythematosus. Visken dosage: 1 Df, Qd. Patient was hospitalized.

5081317-7 | Hypotonia, Muscle Atrophy, Muscular Weakness, Tendonitis, Tremor
Patient was taking Visken (View Usage). Patient experienced the following unwanted or unexpected effects: hypotonia, muscle atrophy, muscular weakness, tendonitis, tremor on Aug 03, 2006 from BRAZIL Additional patient health information: Male patient , 46 years of age, weighting 154.3 lb, was diagnosed with hypertrophic cardiomyopathy and. Visken dosage: Unk, Unk.

5064784-4 | Cardiac Arrest, Cough, Myocardial Infarction
Adverse event was reported on Jun 15, 2006 by a Female patient taking Visken (View Usage) (Dosage: ) . Location: SWEDEN , 67 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cough, myocardial infarction.

5034433-X | Cardiac Arrest, Cough, Myocardial Infarction
on Jun 15, 2006 Female patient from SWEDEN , 67 years of age, was treated with Visken (View Usage). After Visken was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cough, myocardial infarction. Visken dosage: . During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ).

5028657-5 | Cardiac Arrest, Cough, Myocardial Infarction
on Jun 15, 2006 Female patient from SWEDEN , 67 years of age, was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cough, myocardial infarction. Visken dosage: .

4613766-2 | Arrhythmia, Bronchopneumonia, Cardiac Arrest, Cerebral Disorder, Coma, Lung Disorder, Neurological Examination Abnormal, Nosocomial Infection
Patient was taking Visken (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), bronchopneumonia, cardiac arrest (What is cardiac arrest?), cerebral disorder, coma, lung disorder, neurological examination abnormal, nosocomial infection on Jan 31, 2005 from Additional patient health information: Male patient , 74 years of age, . Visken dosage: . During the same period patient was treated with OMIX (View Omix Review and Omix Label ), AMARYL (View Amaryl Review and Amaryl Label ), VIOXX (View Vioxx Review and Vioxx Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

4596553-3 | Arrhythmia, Bronchopneumonia, Cardiac Arrest, Cerebral Disorder, Coma, Lung Disorder, Neurological Examination Abnormal, Nosocomial Infection
Adverse event was reported on Jan 31, 2005 by a Male patient taking Visken (View Usage) (Dosage: ) . Location: , 74 years of age, After Visken was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), bronchopneumonia, cardiac arrest (What is cardiac arrest?), cerebral disorder, coma, lung disorder, neurological examination abnormal, nosocomial infection. During the same period patient was treated with OMIX (View Omix Review and Omix Label ), AMAREL (View Amarel Review and Amarel Label ), VIOXX (View Vioxx Review and Vioxx Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

4569227-2 | Anoxia, Arrhythmia, Bronchopneumonia, Cardiac Arrest, Cerebral Disorder, Coma, Electroencephalogram Abnormal, Lung Disorder
on Jan 31, 2005 Male patient from , 74 years of age, was treated with Visken (View Usage). Patient experienced the following unwanted or unexpected effects: anoxia, arrhythmia (What is arrhythmia?), bronchopneumonia, cardiac arrest (What is cardiac arrest?), cerebral disorder, coma, electroencephalogram abnormal, lung disorder. Visken dosage: . During the same period patient was treated with OMIX (View Omix Review and Omix Label ), AMAREL (View Amarel Review and Amarel Label ), VIOXX (View Vioxx Review and Vioxx Label ), METFORMINE (View Metformine Review and Metformine Label ). Patient was hospitalized.